OptiBiotix Health (LON:OPTI) Share Price Crosses Below Fifty Day Moving Average – Should You Sell?

OptiBiotix Health Plc (LON:OPTI)’s share price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 9.44 and traded as low as GBX 7.90. OptiBiotix Health shares last traded at GBX 7.90, with a volume of 13,042 shares traded.

OptiBiotix Health Trading Up 1.9%

The stock’s 50-day moving average price is GBX 9.44 and its 200-day moving average price is GBX 11.91. The stock has a market cap of £8.16 million, a price-to-earnings ratio of -263.33 and a beta of 1.71.

OptiBiotix Health (LON:OPTI) last announced its earnings results on Tuesday, September 16th. The company reported GBX (1.15) earnings per share for the quarter. OptiBiotix Health had a negative return on equity of 36.76% and a negative net margin of 524.43%.

Insider Activity

In other OptiBiotix Health news, insider David Blain bought 84,053 shares of the stock in a transaction on Wednesday, October 1st. The stock was acquired at an average cost of GBX 1,175 per share, for a total transaction of £987,622.75. Also, insider Stephen O’Hara purchased 95,238 shares of the company’s stock in a transaction on Tuesday, September 23rd. The stock was acquired at an average cost of GBX 11 per share, for a total transaction of £10,476.18. Over the last three months, insiders bought 229,291 shares of company stock valued at $100,309,893. Corporate insiders own 26.82% of the company’s stock.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.